Journal
Cancer Research Communications
Publication Date
2-1-2026
Volume
6
Issue
2
First Page
374
Last Page
382
Document Type
Open Access Publication
DOI
10.1158/2767-9764.CRC-25-0577
Rights and Permissions
Park JC, Berz D, Sharma MR, Malhotra J, Tolcher AW, Hauke RJ, Call JA, Hamm JT, Sanborn RE, Haas NB, Tsai F, Adkins DR, Camidge DR, Spira AI, Senne L, Kalabus J, O'Neill B, Kinkead H, Garcia J, Massarelli E. Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors. Cancer Res Commun. 2026 Feb 1;6(2):374-382. doi: 10.1158/2767-9764.CRC-25-0577 This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. ©2026 The Authors; Published by the American Association for Cancer Research
Recommended Citation
Park, Jong Chul; Adkins, Doug R; and et al., "Phase 1 study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 bispecific antibody, in patients with select solid tumors." Cancer Research Communications. 6, 2. 374 - 382. (2026).
https://digitalcommons.wustl.edu/oa_4/6386
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
